Mirum Pharmaceuticals, Inc.
SEC CIK 1759425 · MIRM · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Grey Michael G | Director · Executive Chairman | filed 2019 - 2026 |
| Walbert Timothy P | Director | filed 2023 - 2026 |
| Heron Patrick J | Director | filed 2019 - 2026 |
| Brege Laura | Director | filed 2019 - 2026 |
| Fischer Laurent | Director | filed 2019 - 2026 |
| Ramasastry Saira | Director | filed 2022 - 2026 |
| Fairey William | Director | filed 2021 - 2026 |
| Cardon Lon | Director | filed 2022 - 2026 |
| Peetz Christopher | Director · President and CEO | filed 2019 - 2026 |
| O'Donnell Niall | Director | filed 2019 - 2022 |
| Mathers Edward T | Director | filed 2019 - 2022 |
| Brosgart Carol L | Director | filed 2021 - 2022 |
| Aynechi Tiba | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Howe Jolanda | SVP, Global Controller | filed 2023 - 2026 |
| Bjerkholt Eric | Chief Financial Officer | filed 2023 - 2026 |
| Radovich Peter | PRESIDENT AND COO | filed 2020 - 2026 |
| Quan Joanne | CHIEF MEDICAL OFFICER | filed 2024 - 2026 |
| Vig Pamela | Head of Research & Development | filed 2019 - 2024 |
| Longpre Lara | Chief Development Officer | filed 2019 - 2024 |
| Clements Ian | SVP Finance & Communications | filed 2019 - 2022 |
| Tucker Edwin Jonathan | Chief Medical Officer | filed 2019 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.